tang
et
al
thromboplastin
time
aptt
antithrombin
activ
fibrinogen
fibrin
degrad
product
fdp
ddimer
detect
use
star
max
coagul
analyz
origin
reagent
diagnostica
stago
saintdeni
franc
survivor
nonsurvivor
normal
abnorm
distribut
quantit
variabl
compar
use
student
test
mannwhitney
u
test
respect
categor
variabl
compar
use
chisquar
test
result
given
mean
standard
deviat
median
interquartil
rang
number
percentag
wherev
appropri
pvalu
consid
statist
signific
data
analyz
use
spss
window
spss
inc
patient
femal
male
ncp
enrol
studi
patient
complet
clinic
inform
laboratori
data
requir
studi
mean
age
diseas
onset
year
rang
year
seventyf
patient
chronic
diseas
includ
cardiovascular
cerebrovascular
diseas
respiratori
system
diseas
malign
tumor
chronic
liver
kidney
diseas
other
patient
receiv
antivir
support
therapi
diagnosi
end
februari
patient
discharg
patient
die
rest
patient
remain
hospit
stabl
condit
coagul
paramet
admiss
survivor
nonsurvivor
compar
tabl
base
detect
system
report
rang
ddimer
fdp
late
stage
ncp
level
fibrinrel
marker
ddimer
fdp
moder
markedli
elev
death
suggest
common
coagul
activ
secondari
hyperfibrinolysi
condit
patient
role
coagulopathi
sever
novel
coronaviru
pneumonia
ncp
remain
clarifi
convent
coagul
paramet
consecut
patient
ncp
retrospect
analyz
abnorm
coagul
result
associ
poor
prognosi
exist
dissemin
intravascular
coagul
common
death
ncp
previou
studi
gralinski
thank
patient
involv
studi
n
tang
x
wang
collect
clinic
data
process
statist
data
n
tang
li
draft
revis
manuscript
z
sun
design
guid
studi
author
declar
conflict
interest
note
ddimer
cutoff
level
defin
accord
previou
report
deriv
sampl
intens
care
abbrevi
dic
dissemin
intravascular
coagul
isth
intern
societi
thrombosi
haemostasi
ncp
novel
coronaviru
pneumonia
